National Monitoring Standards for RWHAP Part A Recipients
Resource updated 08/21/2023
Resource updated 08/21/2023
Instructions on how all Ryan White HIV/AIDS Program (RWHAP) Part C recipients can access, complete, and submit the RWHAP Part C Allocations Report.
Note: RWHAP annual Allocations reports do not serve as a source for determining the total amount of funds awarded and unspent by recipients.
Resource updated 12/22/2023
Resource updated 09/19/2023
Resource updated 09/19/2023
Resource updated 09/19/2023
Blog updated 03/28/2024
Resource updated 09/14/2023
Resource updated 04/03/2024
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
California’s AIDS Drug Assistance Program (ADAP) and Pre-Exposure Prophylaxis Assistance Program (PrEP-AP) provide access to life-saving medications and insurance assistance for eligible California residents living with or at risk of acquiring HIV. This presentation will explore the efficacy of various program policy changes implemented by California during the COVID-19 pandemic.
Resource (Conference Presentation) updated 09/14/2023
Following Hurricane Ida in New Orleans, Tulane ID providers utilized an innovative communication model to contact patients using a Google Voice number to act as the clinic call back number. Using this model, 88 out of 132 patients were successfully reached, with 36 percent of those that answered requiring urgent refills.
Resource (Conference Presentation) updated 09/14/2023
Resource updated 12/21/2023
This series of videos covers the fundamental concepts behind the Ryan White Services Report (RSR) for new and experienced grantees.
Resource updated 01/29/2024
Resource updated 03/05/2024
NASTAD’s National AIDS Drug Assistance Program (ADAP) Formulary Database provides an online, searchable, publicly available resource detailing state-by-state ADAP coverage of medications, including HIV antiretroviral (ARV) treatments, “A1” Opportunistic Infections (A1 OI) medications, treatments for hepatitis B and C, mental health and substance use treatment medications, and various vaccines and laboratory tests.
Resource updated 03/07/2024